Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)

Clinical trial NCT00684970 · UNKNOWN

Trial details

NCT number: NCT00684970
Sponsor: Tiltan Pharma Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer (CRPC)

Start date: 2009-03-01
Primary completion: 2014-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.